ym 58483 has been researched along with Eosinophilia, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funatsu, M; Ishikawa, J; Kubota, H; Miyazaki, Y; Ohta, M; Okamoto, Y; Takeuchi, M; Yonetoku, Y; Yoshimura-Ishikawa, N; Yoshino, T | 1 |
1 other study(ies) available for ym 58483 and Eosinophilia, Pulmonary
Article | Year |
---|---|
Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilides.
Topics: Anilides; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Enzyme Inhibitors; Female; Humans; Hypersensitivity; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Male; Mice; Pulmonary Eosinophilia; Pyrazoles; Rats; Rats, Inbred BN; Structure-Activity Relationship; T-Lymphocytes; Thapsigargin | 2008 |